Long for a Longtime or until they make me an offer I cant' Refuse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Does anyone here think the good doctor is not going to issue a kick ass PR,
to insure the PPS does't get crushed.
My experience is the up-listing is announced at the same time the reverse split is announced. Add phase 2a results being presented at 11/7 conference and we have a winner.
Happy I grabbed more today.
Keep in mind the big TUTES need to have the PPS $5 bucks or better.
The good doctor has a plan.
Now I understand why we had no PR on the 11/7 conference.
Will be PRed with RS news.
educated guess!
Warrants being exercised...
I think this article will piss the good doctor off.
PR about announcing PH2a result on Nov. 7th before EOW.
JMHO
Bought a few myself. 1.60
Great Post.....Uplisting will remove some of this noise.
Congrats...you have earned my last IGGY. I would recommend to all, Ignore this basher...lots of bad noise on the board.
I found it interesting that TD Ameritrade decided to list this BS as news.
This may be enough to make the Good Doctor put out a PR to crush these idiots.
http://www.sitejabber.com/reviews/www.thestreetsweeper.org
Some reviews of this POS website.
One of reasons for drop http://thestreetsweeper.org/
Anavex Life Sciences: Biotech Pump Goes On And On And ?
by Sonya Colberg, Senior Editor, 10/6/2015 9:58:48 AM
If we didn’t know better, we’d think Anavex Life Sciences Corp. (OTC: AVXL) enthusiasts had ripped off a “Saturday Night Live” sketch featuring pump-you-up guys Hans and Franz.
Picking up three patents and one patent application, Anavex conducted a reverse merger in 2007 and switched from a digital-to-photo-print business targeting corner stores into a biotech company targeting Alzheimer’s.
Today, the company has no commercial product, hasn’t earned a penny since inception and does “not anticipate earning any revenues” until it can convince some other company to come aboard.
The company has lost $61.8 million over about 12 years of operations and is living on the ragged edge of survival.
And don’t let the stock price fool you. Though it sports an astonishing $230 million-plus market valuation, this stock is worth a fraction of today’s price.
The company has not responded to TheStreetSweeper’s request for comment but investors may find other viewpoints here. We’re just scratching the surface with this first look at a batch of highly promotional biotech stocks poised to dive.
*”We’re Here to Pump (clap) You Up!”
The 25 top biotech giants such as Johnson & Johnson and Novartis and Eli Lilly do not rely on hype to push their stock.
But Anavex has everyone from the CEO to pump sites to message board fans clapping their hands and cheering on Anavex with, “We’re here to pump you up!”
The chief executive officer, Christopher Missling, had this to say in a recent interview:
“Anavex has now a team of big pharma and biotech experts, doubled the number of Scientific Advisors which is mostly Medical Doctors, raised a company's record amount of $10M in one funding transaction, advanced after that quickly into Phase 2a, licensed additional promising compounds into the company. Anavex is significantly more advanced than in 2007.”
Yet Anavex filings say it operates with just “four (4) full-time employees, and we retain several independent contractors on an as-needed basis.” (Don’t miss the section below titled “Executive Compensation” to put employee compensation into perspective.)
Other concerning promotional efforts include:
The CEO sounds highly promotional - talking about reversing the disease and stopping the disease today (despite having its experimental drug just barely in the human testing stage involving dose toleration of just 32 subjects) - in this one video of four Anavex videos on Wide World of Stocks. WWOS is a site Timothy Sykes connected with Viral Genetics and one that also discloses that its employees sometimes receive investments in companies it features.This series just begged for a dose of the brash objectivity of SNL character
Could have been a SEC thing...
I do think the good doctor gave us another strong signal.
(this was not an accident)
Big money starting to pile in.....
Were You able to pay commissions?
Keep shorting Idiot....
This was posted on the Anavex FaceBook page by a follower:
CTAD 2015 Program for Saturday November 7th. 9.45 am OC49 - New Exploratory Alzheimer’s Drug ANAVEX 2-73: Clinical Cognitive Improvement observed in Mini Mental State Examination (MMSE) and other Cognitive Markers in a Phase 2a Study in mild-to moderate Alzheimer’s Patients
Steve Macfarlane, MD (1), Marco Cecchi, PhD (2), Dennis Moore, PhD (2), Paul Maruff, PhD (3), Anastasios Zografidis,PhD (4), Christopher Missling, PhD (4)
(1) Caulfield Hospital, Melbourne, Australia; (2) Neuronetrix, KY, USA; (3) Cogstate, Melbourne, Australia; (4) Anavex Life Sciences, Corp., New York, NY, USA
This PR cannot be far off...
I think we see PR announcing Nov. 7th conference announcing PH 2a results before end of week.
The care givers interviews will trump all medical mumbo jumbo. IMVHO
Anyone who owns or is thinking of owning this stock should listen to the conference presentation. http://wsw.com/webcast/ladenburg/avxl.
I was impressed on how positive and confident the good doctor sounded.
Good stuff to come.
Time will tell. I am looking forward to hearing the presentation. This is his first presentation after the July poster.
He is looking for investors. Why wouldn't he present new data?
"Management plans to be available for one-on-one meetings with members of the investment community at the conference. Attendees are invited to contact Anavex at ir@anavex.com to request a meeting with management.
A live audio webcast of the presentation will be available under the conference website at http://wsw.com/webcast/ladenburg/avxl. Investors may also view an archived version of the presentation on anavex.com."
I do believe the good doctor will present an update at this conference.
The PPS should react to this as it did the last time a catalyst date was announced. JMHO
Comment from today's KKD article:
Another interesting comment from Gilead COO John Milligan during the conference was about doing due diligence behind the scene. Milligan's comments suggest that the company is looking at a number of opportunities and may make a move if "things play out in favor" i.e. if the companies Gilead is watching report positive data and the valuation is right.
Again!
The silence is deafening.
So many positive PR's that can be issued.
Something Big is happening,
Keep the faith AVXL longs.
You will be rewarded.
Do not let the crooks take your shares.
Another way to keep him away....do not respond to him and he will magically disappear.
Thanks, I will be more careful in the future.
I wasn't aware of that. I would not want to get her in trouble.
But I find the whole scenario very interesting.
Jockimo, by informing Anavex Pr about my email exchange with Erica, it has seemed to shut her down.
I have emailed her a few time since and no response.
NO – Dr. Missling has NOT registered yet. And, from what I understand, he may be bringing someone…?
Did she let a cat out of the bag?.
Looks to me they are getting their ducks in a row for up-listing or someone doing Due Diligence.
Join the Group and give the clown an iggy....Board is much better without him.
Has Google added an "A" to their alphabet yet?
I think the good doctor is waiting for the FED decision before any PR.
Why waste a good PR on a rocky market.
As always Wolf..... U R the best.
I think the good doctor also knows how to play the shorts.
Why don't we all ignore the Board Clown. He will go away.